Top 50 Ai Diagnostics in Europe

The startup has developed a digital diagnostics platform that utilizes artificial intelligence for genetic analysis and clinical decision support, enhancing the traceability and interoperability of bioinformatics data. This technology enables researchers and clinicians to efficiently access and reuse critical information, thereby expediting the diagnosis process for various diseases.

This healthcare technology firm utilizes AI and data analytics to provide actionable insights from patient data, enabling precise diagnostics and tailored treatment plans. By integrating these capabilities into clinical workflows, the platform enhances decision-making and improves the quality of patient care.

The startup develops an artificial intelligence-based healthcare technology that utilizes MRI and multi-omics biomarkers to enhance cancer detection and diagnosis. By providing accurate and cost-effective reporting tools, the technology enables clinicians to improve the speed and accessibility of cancer screening.

The startup develops artificial intelligence technology for medical image analysis, specifically targeting skin cancer diagnosis in clinical settings. By enhancing diagnostic precision, the solution improves the efficiency of care workflows and supports medical personnel in making more accurate disease assessments compared to traditional methods.

The startup develops a medical analysis platform that integrates artificial intelligence with computational pathology to enhance diagnostic accuracy in cancer detection. By facilitating real-time collaboration between pathologists and AI, the platform improves decision-making in clinical diagnostics and drug development, ultimately increasing survival rates for cancer patients.

dehaze integrates medical AI models into clinical workflows to enhance diagnostic accuracy and prognostic capabilities tailored to individual patient data. This approach addresses the limitations of standardized treatment guidelines by providing personalized healthcare solutions based on unique health profiles.

The startup has developed an AI-driven chest X-ray radiology suite that automates the diagnosis and reporting of healthy patients by identifying normal X-ray images and generating preliminary reports only for cases with high confidence in abnormalities. This technology enables radiologists to concentrate their efforts on cases that require further examination, improving diagnostic efficiency and patient care.

The startup develops nanotechnology-based diagnostic test kits that utilize photonics and AI for rapid and reliable bacterial classification at the point of care. These kits provide affordable diagnostics, enhancing patient care and mitigating the risks associated with antimicrobial resistance.

The startup offers an artificial intelligence-based healthcare information platform that transforms health data into an interactive format with clear explanations and personalized insights. This platform enables users to make informed health and well-being decisions by providing tailored coaching and easy access to their health information.

Oxford Immune Algorithmics develops Algocyte®, a precision diagnostics platform that utilizes Artificial General Intelligence to create digital blood-based twins for remote health monitoring. This technology addresses the challenges of chronic disease management and early detection by providing personalized risk assessments and predictive insights based on individual health data.

Floy® develops certified artificial intelligence to assist radiologists in identifying hard-to-detect abnormalities in medical imaging. This technology aims to enhance diagnostic accuracy and reduce the risk of misdiagnosis in conditions such as cancer, cardiovascular diseases, and dementia.

The startup employs AI and vocal biomarker analysis to perform health assessments for lung and cardiorespiratory conditions via smartphones. This technology enables users to monitor their respiratory health in real-time, providing immediate insights without requiring specialized medical equipment.

AIDY Health provides AI-powered health assistance products that utilize ambient home health monitoring to enhance access to care for individuals facing health issues. By reducing waiting times for support, the platform enables timely interventions and improves overall patient outcomes.

DasLab offers a Diagnostics API that integrates lab data into digital patient records, enhancing interoperability among health insurers, providers, and laboratories. The platform addresses the challenge of fragmented diagnostic access, enabling timely and accurate medical decisions through streamlined workflows for tests and vaccinations.

LightHearted AI develops a laser-based diagnostics device that utilizes advanced AI to detect heart conditions by acquiring biomarkers from a distance. This contactless technology provides rapid and accurate diagnostic reports, making heart disease detection more accessible and affordable.

DoMore Diagnostics develops artificial intelligence-based diagnostic technology that accurately predicts cancer progression and prognosis. This approach addresses the lack of objective methods in cancer diagnostics, enabling personalized treatment plans and improving patient outcomes.

Aignostics utilizes multimodal AI and proprietary datasets to enhance precision diagnostics in pathology, enabling the identification of novel drug targets and improving the analysis of complex imaging and omics data for clinical research. Their foundation model achieves over 90% accuracy on histopathology benchmarks while significantly reducing the amount of training data required for new model development.

Spotlight Medical develops AI-driven prognosis tests that utilize extensive patient data to enhance treatment selection for cancer care. The company addresses the challenge of inadequate treatment options by providing personalized insights into each patient's unique disease profile, aiming to improve outcomes and increase the likelihood of remission.

Mindpeak develops AI-based diagnostic software that automates the detection, quantification, and classification of cancer biomarkers in histological tissue samples. This technology enhances the efficiency and accuracy of clinical pathology, enabling pathologists to focus on complex cases while reducing the time required for routine analyses.

The startup offers an API-driven test management system that integrates remote diagnostics and health checks into existing patient care pathways for healthcare providers and insurers. This system enhances patient access to clinical care while providing data analytics and customer support to improve health outcomes.

SeqOne provides a clinical decision support platform that utilizes AI-driven bioinformatics to analyze next-generation sequencing (NGS) data for germline and somatic variants. The platform enhances diagnostic accuracy and efficiency by identifying complex genomic events that standard pipelines often overlook, thereby improving patient outcomes in precision medicine.

Dxcover is developing a multi-cancer diagnostic platform that utilizes liquid biopsy and an AI engine for the early detection of brain tumors. This technology aims to improve patient survival rates by enabling earlier diagnosis, addressing the critical challenge of late-stage cancer detection.

The startup develops an artificial intelligence-powered diagnostic software that utilizes video and sensor data, combined with computer vision and machine learning, to monitor and analyze epilepsy seizures. This platform provides neurologists and patients with critical insights into seizure patterns, enhancing treatment decisions and patient care.

The startup develops AI-augmented biosensing solutions that analyze unique disease biomarkers to enhance diagnostic accuracy. This technology aims to reduce the risk of misdiagnosis and improve patient outcomes by providing timely and precise health insights.

Ophiomics develops in vitro diagnostic devices that utilize artificial intelligence and genomics to enhance early cancer detection and optimize treatment selection. Their technology integrates machine learning algorithms with clinical and biomarker data to improve decision-making for clinicians, ultimately aiming to enhance patient outcomes in oncology.

The startup develops a remote diagnostic device that generates high-quality medical-grade data through secure encryption and interchangeable modules. This technology enables patients to conduct tests accurately and access their medical records anytime and anywhere, addressing the need for convenient and reliable health monitoring.

This startup provides AI-powered software that assists medical professionals with diagnosis and treatment planning. It analyzes patient data and discharge letters to offer individualized diagnostic suggestions and therapy recommendations, helping doctors predict treatment courses.

The startup develops medical software that utilizes artificial intelligence to analyze electroencephalography recordings, generating simplified parameters for clinical decision-making. This technology enhances patient care in intensive settings by improving the quality and cost-effectiveness of brain monitoring solutions.

The startup has developed a speech analysis platform that utilizes artificial intelligence to detect vocal biomarkers associated with mild cognitive impairment and mild dementia. This technology enables healthcare professionals to integrate early detection of mental health conditions into patient care plans, improving diagnosis and monitoring efficiency.

The startup has developed a cloud-based health diagnostics platform that utilizes AI-enhanced Nuclear Magnetic Resonance to convert blood samples into digital representations, creating a digital twin of patients. This technology provides affordable health testing for preventative care and precision medicine by delivering metabolic insights derived from blood metabolism measurements.

Keen Eye Technologies is a health tech company focused on developing advanced diagnostic tools that utilize machine learning algorithms to analyze medical imaging data. The company aims to enhance early disease detection and improve patient outcomes by providing healthcare professionals with accurate and timely insights.

This startup provides an AI-driven platform that analyzes medical bills to identify and correct errors such as upcoding, unbundling, duplicate charges, and incorrect insurance billing. The software helps individuals and organizations protect themselves from unfair medical billing practices.

The startup operates a network of diagnostic laboratories that utilize telehealth and remote monitoring technologies to provide accessible healthcare services. By focusing on patient needs, the company enhances diagnostic capabilities and improves patient quality of life through efficient digital health solutions.

This startup develops digital assessment tools that analyze conversational patterns to detect early signs of cognitive decline. Their AI-powered technology identifies dementia biomarkers non-invasively, providing healthcare professionals with data for earlier diagnosis and intervention.

Presymptom Health develops AI-based diagnostic blood tests that provide rapid and accurate detection of infections, including sepsis, with a ruling-out accuracy of 95-99%. Their technology addresses the critical need for timely infection diagnosis, reducing unnecessary hospital admissions and combating antimicrobial resistance.

The startup develops a medical neurotrophic technology that utilizes artificial intelligence and big data for remote health monitoring and predictive analytics. This technology enhances patient diagnosis by enabling healthcare providers to track health status and identify patterns in patient data effectively.

Cancilico develops AI-powered diagnostic solutions that utilize image analysis to enhance the accuracy and efficiency of diagnosing hematological cancers. The company provides AI-driven services for medical research, addressing the need for improved diagnostic precision in the healthcare industry.

The startup develops an AI-enabled remote patient monitoring tool that detects chronic conditions and associated comorbidities through continuous health data analysis. This technology enables healthcare providers to monitor patients' health remotely, ensuring timely interventions and improved patient outcomes.

This startup utilizes machine learning algorithms to provide personalized diagnoses, prognoses, and treatment plans, enhancing the accuracy of patient care. By transforming traditional statistical methods into tailored solutions, it addresses the need for individualized healthcare experiences and improved patient outcomes.

Vital Beats employs AI algorithms to analyze data from implanted cardiac devices, delivering real-time diagnostics and tailored treatment plans for patients with cardiac conditions. This technology enhances patient monitoring and facilitates timely medical interventions, ultimately improving clinical outcomes.

medicalvalues offers an AI-powered platform that streamlines medical diagnostics for laboratories and clinics. It provides pre-built AI models and tools to optimize diagnostic workflows, standardize data, and improve patient care.

CheckApp is an AI-powered health diagnostics platform that utilizes image analysis of facial and tongue photos to identify early signs of potential health issues. The platform delivers personalized health reports with actionable recommendations, enabling users to monitor their well-being and make informed health decisions.

The startup develops an artificial intelligence-driven medical data platform that enables patient-level data analytics for clinicians through real-time access and integration with existing healthcare systems. This platform enhances clinical decision-making, improves patient outcomes, and reduces operational costs by streamlining access to critical patient information.

AINOSTICS develops AI algorithms and MRI measurement techniques to identify early biological signs of neurological disorders, such as Alzheimer's disease and multiple sclerosis. Their platform enhances clinical diagnosis and treatment planning by providing automated, data-driven insights from multi-modal imaging and non-imaging data.

MedBrain is a diagnostic support system that guides healthcare professionals in resource-scarce settings through clinical interviews, physical examinations, and differential diagnosis to achieve accurate diagnostic predictions. It addresses the global diagnostic gap by providing reliable clinical diagnosis tools where access to trained personnel and diagnostic resources is severely limited.

The startup has developed a clinical decision intelligence platform that integrates current clinical guidelines with AI-driven analyses of historical medical decisions to enhance diagnostic assessments and treatment recommendations. This technology enables healthcare professionals to deliver more accurate, consistent, and personalized patient care.

Humanbytes offers a curated portfolio of AI solutions to enhance diagnostic capabilities and streamline clinical workflows in healthcare. Their platform integrates best-in-class AI technologies for specialties like radiology, neurology, and digital pathology, simplifying AI deployment for hospitals and clinics.

This medtech startup develops AI-based clinical decision support modules that utilize generative manifold learning technology to analyze patient health data. Their platform provides personalized diagnosis and treatment recommendations, enhancing researchers' understanding of medical conditions and improving patient outcomes.

The startup develops radiology tools that utilize advanced algorithms to automate the generation of radiological reports for X-ray, CT, and MRI examinations. This platform reduces the time required for diagnostic descriptions, enabling faster patient diagnoses and improving access to high-quality imaging services.

The startup has developed a treatment management tool that utilizes artificial intelligence for training and clinical feedback on skin lesions suspected of cancer. This technology enhances the diagnostic capabilities of healthcare professionals, enabling more accurate skin cancer assessments for thousands of patients.